Evaluating Parent Delivered Interventions for Children With Autism

July 13, 2023 updated by: Antonio Hardan, Stanford University
The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is effective in improving child social communication and reducing parent stress.

Study Overview

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Stanford University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for autism participants:

  • Children between the ages of 1.6 and 17.11 years of age
  • Males and females
  • Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed
  • Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject

Inclusion Criteria for developmentally delayed participants:

  • Will have an age range between 1.6 and 17.11 years of age
  • Males or females
  • Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation
  • Have historical evidence of significant abnormal developmental milestones as determined by neurological history
  • Receiving or will receive a parent delivered intervention
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject

Exclusion Criteria for autism participants:

  • Is medically unstable (e.g., more than one seizure a month)
  • Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)

Exclusion Criteria for developmentally delayed subjects:

  • Is medically unstable (e.g., more than one seizure a month)
  • Has a diagnosis of ASD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Developmentally Based Intervention
The developmentally based intervention is grounded in a development theory, that focuses on child-directed interactions with warm and caring individuals that aid in acquiring missed developmental and functional milestones.
The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).
Experimental: Behaviorally Based Intervention
The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).
The behaviorally-based intervention is a treatment model that uses the principles of Applied Behavior Analysis (Koegel, Openden, Fredeen, & Koegel, 2006) to increase children's adaptive behaviors and decrease maladaptive behaviors.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in CGI-S (Clinical Global Impression - Severity)
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in SRS (Social Responsiveness Scale)
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in CDI (Communicative Development Survey) Score
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in social and communication behaviors as assessed by standardized laboratory observations
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in VABS (Vineland Adaptive Behavior Scale) Score
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in social and communication behaviors as assessed from home videos
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in PSI (Parenting Stress Index) Score
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in FES (Family Empowerment Scale) Score
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in frequency and duration of investigation therapy
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12
Change in demographics data
Time Frame: Difference from Baseline to Week 12
Difference from Baseline to Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonio Y Hardan, M.D., Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2010

Primary Completion (Actual)

February 18, 2022

Study Completion (Actual)

February 18, 2022

Study Registration Dates

First Submitted

June 17, 2013

First Submitted That Met QC Criteria

June 19, 2013

First Posted (Estimated)

June 20, 2013

Study Record Updates

Last Update Posted (Actual)

July 14, 2023

Last Update Submitted That Met QC Criteria

July 13, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autistic Disorder

Clinical Trials on PACE Therapy

3
Subscribe